PEPTIDE GUARDIANResearch literacy for peptides
Free guide

Get the Guardian Field Guide

Every compound on this site in one guide: what it is, what studies found, and where it stands with regulators. Sign up and it opens right away.

Peptide Guardian is published by the founder of AMINOSWORK, a research peptide supplier. This site has no shop, and every mention of AMINOSWORK is labelled.

What is inside

  • 26 compounds in 8 subjects.
  • For each one: what it is known for, what studies show, its FDA status and its status in sport.
  • An evidence level on every entry: 6 animal and cell studies only, 12 early human trials, 3 late-stage human trials, 5 approved medicine.
  • A link from every entry to a full page where each finding has its source.

A sample entry

BPC-157

Early human trials

Best known as the 'healing peptide' talked about for tendon, muscle and gut injuries.

What studies show. Rat studies reported faster healing of injured tendons, muscle and gut; no controlled human trial of tendon or muscle injury has results, and a 53-person colitis trial showed no clear benefit.

  • A lab-made chain of 15 amino acids. It is not an approved medicine in any country.
  • In rats, several studies reported faster healing of injured tendons, ligaments, muscle and gut. Much of that work comes from one research group.
  • In people, the FDA counted five small studies in 2026. The longest lasted two weeks, and none was a controlled trial of tendon, ligament or muscle injury.
FDA status
Not approved. Not on the pharmacy compounding list. Named in a draft federal policy (30 October 2026) that is not an approval.
In sport
Prohibited at all times; named in class S0 (non-approved substances), 2026 and 2027.
Studies on the full page
17, of which 6 in people

Full BPC-157 page, with every source

This page summarises published research and public records for education. It is not medical advice and it is not a guide to using any compound. If something here is wrong or out of date, tell us and we will correct it.